Translational research on advanced therapies.

Correction: Genetic Diversity of the KIR/HLA System and Outcome of Patients with Metastatic Colorectal Cancer Treated with Chemotherapy

There are errors in some of the authors’ affiliations. Please refer to the correct affiliations below: Dr. Laura Caggiari, Dr. Mariangela De Zorzi and De Re Valli: Bio-Proteomics Core Facility, Experimental and Clinical Pharmacology, Department of Translational Research (molecular oncology, advanced diagnostics and cell therapies) Dr Toffoli Giuseppe and Dr. Erika Cecchin: Experimental and Clin...

Targeted therapies in melanoma: Translational research at its finest

The therapeutic landscape for advanced melanoma has expanded in recent years. This expansion has largely been driven by investigational work in melanoma tumor biology and immunology that has been successfully translated to the clinical setting. Molecular evidence generated through benchside experimentation identified BRAF and MEK as key molecular targets in melanoma. This commentary will highli...

Translational Oncogenomics and Human Cancer Interactomics: Advanced Techniques and Complex System Dynamic Approaches

An overview of translational, human oncogenomics, transcriptomics and cancer interactomic networks is presented together with basic concepts and potential, new applications to Oncology and Integrative Cancer Biology. Novel translational oncogenomics research is rapidly expanding through the application of advanced technology, research findings and computational tools/models to both pharmaceutic...

Editorial: New Generation of Psychotherapies Inspired by Cognitive Neuroscience Development: Emergence of Neurocognitive Therapies

Regenerative Medicine: Progressing Toward Cures

What an exciting year in stem cell science and translational medicine! STEM CELLS Translational Medicine (SCTM) and its sister journal, STEM CELLS (www.Stemcells.Com, @StemCellsJournal), with its focus on a better understanding of stem cell function, continued to publish remarkable, groundbreaking findings that are moving the field forward. And, in the regulatory arena, the U.S. Food and Drug A...